Please ensure Javascript is enabled for purposes of website accessibility



Founded in 1853, Sheppard Pratt, in Towson, is one of the oldest private psychiatric hospitals in the country. But the nonprofit provider of mental health, special education, substance use services and more still prides itself on being an innovator in the field of mental health care.

One of its newest innovations is the Institute for Advanced Diagnostics. Opened in March 2022, the institute, which includes the new Center of Excellence for Psilocybin Research and Treatment, combines the hospital’s clinical expertise for treating mental illnesses with a research center. The goal is to help people who have not been helped by previous treatments and medications.

The Institute also houses Sheppard Pratt’s existing Electroconvulsive Therapy and Transcranial Magnetic Stimulation services, which are neurostimulation treatments that target the areas of the brain thought to regulate mood.

“There is a tremendous need for mental health care in local communities, across the nation and around the world. People are struggling to find their best path forward,” said Dr. Harsh K. Trivedi, president and CEO of Sheppard Pratt. “The institute offers innovative treatments and access to the most advanced psycho-pharmacology to help people find the right modality that will work best for them.”

“Every day at Sheppard Pratt we are looking at mental illness in different ways to achieve improved outcomes,” said Dr. Scott Aaronson, chief science officer for the institute. The new institute, he said, showcases “the clinic of the future and integrates many of our existing and future clinical priorities.

“It will give researchers a new platform to engage with Sheppard Pratt as we build care models for the future.”

This is a winner profile from The Daily Record's Health Care Heroes awards. Information for this profile was sourced from the honoree's application for the award.